BRAF and melanoma: Finally, it was reported that ectopic expression of RAC1P29S in BRAF mutant melanoma cells generates resistance to BRAF inhibition and that three patients with the mutation responded particularly poorly to a BRAF inhibitor (Van Allen et al., 2014).